Ossiam Has $494,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Ossiam trimmed its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 84.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,434 shares of the company's stock after selling 30,324 shares during the period. Ossiam's holdings in Colgate-Palmolive were worth $494,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $32,000. Briaud Financial Planning Inc bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have commented on CL. Stifel Nicolaus lowered their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reiterated a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a report on Friday, April 11th. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company increased their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $102.17.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $95.76 on Wednesday. The firm has a market capitalization of $77.67 billion, a PE ratio of 27.20, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The firm has a 50-day moving average price of $91.63 and a 200 day moving average price of $92.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm posted $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.17%. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is currently 59.09%.

Colgate-Palmolive declared that its Board of Directors has initiated a stock repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are often a sign that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.